О семинаре "Генная терапия и редактирование генома с помощью CRISPR-Cas9: подходы и решения"
16 апреля 2018 года в ФГБУ "НИИ гриппа" Минздрава России состоялся семинар "Генная терапия и редактирование генома с помощью CRISPR-Cas9: подходы и решения" (Gene therapy and genome editing using CRISPR-Cas9: approaches and solutions) с участием представителей Бостонского и Вашингтонского университетов.
В ходе семинара были заслушены следующие доклады:
Cellular Mechanisms that Establish and Maintain HIV Latency
Andrew J. Henderson, PhD
Assistant Dean Graduate Medical Sciences, Department of Medicine and Microbiology, Section of Infectious Diseases, Boston University School of Medicine, USA
AAV-mediated delivery of CRISPR/Cas9 and related nucleases for cure of persistent viral infections
Keith R. Jerome, MD, PhD
Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Professor and Head, Virology Division, Department of Laboratory Medicine, University of Washington, USA
Microcapsules as universal biocompatible platform for intracellular delivery of coding/noncoding nucleic acids
1RASA center in Tomsk, Tomsk Polytechnic University, Tomsk, Russia
2Peter the Great St. Petersburg Polytechnic University, Saint-Petersburg, Russia
3Research Institute of Influenza, Saint-Petersburg, Russia
4Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, Russia,
5School of Engineering and Materials Science, Queen Mary University of London, United Kingdom
Hematological malignancies in HIV-patients: from stem cell transplantation to gene therapy
Boris Afanasyev, MD, PhD
Professor, Director of Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation at the First I. Pavlov State Medical University, St. Petersburg
Marina Popova, MD, PhD, hematologist, associate professor, Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation at the First I. Pavlov State Medical University, St. Petersburg
CCR5 gene editing in hematopoietic stem cells by CCR5-Uco-TALEN
Alena Shakirova, MS
Molecular biologist, Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation at the First I. Pavlov State Medical University, St. Petersburg